Table 2.
Association between HBV DNA level at study entry and subsequent risk of HCC n (%)
| HBV DNA level (log10 copies/mL) | HCC patients (n = 170) | Control patients (n = 276) | Adjusted odds ratio (95% CI) |
| 1 undetectable | 44 (25.9) | 186 (67.4) | 1.000 (reference) |
| 2 (2.69-3.99) | 5 (2.9) | 46 (16.7) | 0.465 (0.172-1.259) |
| 3 (4.00-4.99) | 12 (7.1) | 19 (6.9) | 2.834 (1.237-6.492) |
| 4 (5.00-5.99) | 30 (17.6) | 4 (1.4) | 48.403 (14.392-162.789) |
| 5 (6.00-6.99) | 38 (22.4) | 5 (1.8) | 42.252 (14.784-120.750) |
| 6 (≥ 7.00) | 41 (24.1) | 16 (5.8) | 14.819 (6.992–31.411) |
Adjusted for age at enrollment (continuous variable), cigarette smoking, alcohol consumption and family history of chronic liver diseases.